| 标题 |
274MO Pooled efficacy and safety with tremelimumab plus durvalumab in participants (pts) with unresectable hepatocellular carcinoma (uHCC) from the mainland China extension cohort, and Hong Kong (HK) and Taiwan (TW) subgroups from the global cohort in the phase III HIMALAYA study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:G.K.K. Lau; S. Qin; W. Wang; M. Zhang; H. Zhang; et al 出版日期:2025-12-23 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)